Borriello Lucia, Condeelis John, Entenberg David, Oktay Maja H
Department of Anatomy and Structural Biology, Montefiore Medical Center, Einstein College of Medicine, Bronx, NY 10461, USA.
Gruss-Lipper Biophotonics Center, Montefiore Medical Center, Einstein College of Medicine, Bronx, NY 10461, USA.
J Clin Med. 2021 May 27;10(11):2340. doi: 10.3390/jcm10112340.
Although metastatic disease is the primary cause of mortality in cancer patients, the mechanisms leading to overwhelming metastatic burden are still incompletely understood. Metastases are the endpoint of a series of multi-step events involving cancer cell intravasation, dissemination to distant organs, and outgrowth to metastatic colonies. Here we show, for the first-time, that breast cancer cells do not solely disseminate to distant organs from primary tumors and metastatic nodules in the lymph nodes, but also do so from lung metastases. Thus, our findings indicate that metastatic dissemination could continue even after the removal of the primary tumor. Provided that the re-disseminated cancer cells initiate growth upon arrival to distant sites, cancer cell re-dissemination from metastatic foci could be one of the crucial mechanisms leading to overt metastases and patient demise. Therefore, the development of new therapeutic strategies to block cancer cell re-dissemination would be crucial to improving survival of patients with metastatic disease.
尽管转移性疾病是癌症患者死亡的主要原因,但导致转移性负担过重的机制仍未完全明确。转移是一系列多步骤事件的终点,这些事件包括癌细胞侵入血管、扩散至远处器官以及生长为转移瘤。在此,我们首次表明,乳腺癌细胞不仅从原发性肿瘤和淋巴结中的转移结节扩散至远处器官,还可从肺转移灶扩散至远处器官。因此,我们的研究结果表明,即使切除原发性肿瘤后,转移性扩散仍可能继续。倘若重新扩散的癌细胞到达远处部位后开始生长,那么癌细胞从转移灶重新扩散可能是导致明显转移和患者死亡的关键机制之一。因此,开发新的治疗策略以阻断癌细胞重新扩散对于提高转移性疾病患者的生存率至关重要。